Healthy volunteers test new drug combinations in Early-Stage trial

NCT ID NCT07267221

Recruiting now Knowledge-focused Sponsor: Daewoong Pharmaceutical Co. LTD. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-phase study is testing three experimental drugs (DWJ1622, DWC202313, and DWC202314) in 36 healthy adults. The goal is to see how the body absorbs and processes these drugs and to check for any safety issues. Participants will take the drugs by mouth after eating. This trial is not intended to treat any disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

DWJ1622, DWC202313, DWC202314

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY VOLUNTEERS

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

H Plus YANGJI Hospital
RECRUITING

Seoul, Gwanak-gu, 08779, South Korea

Contact Phone: •••-•••-••••